New coronaTRAVEL.world site provides info on quarantine & COVID test requirements
Bio Nano Consulting (a member of the AquAffirm Group) is pleased to announce that its digital team is continuing to respond to challenges created by the global COVID-19 pandemic. BNC’s latest COVID-19 response is the travel assistance website: coronatravel.world. This new site provides continually updated information on restrictions such as multi-day quarantines and test requirements imposed on travel between countries, together with the latest pandemic predictions so that travellers can make informed decisions.
This new offering adds to the portfolio of platforms already developed by Bio Nano’s digital team to address the COVID-19 pandemic, including the covidsim.org platform, an interactive, user-friendly software platform enabling government ministers, public health officials, scientists, and interested individuals to deploy sophisticated epidemiological prediction tools. The web-based tool has been used to inform economic and political decisions concerning intervention/restriction strategies and related resource allocation in over 135 mainly low- and middle-income countries (LMICs).
Once international travel recommences following lockdowns in various countries BNC anticipates international business travellers and tourists will view the coronaTRAVEL.world website as an important new tool for planning trips abroad. ‘This travel assistance website has been designed to bring together in one location all the critical information necessary to plan trips abroad during this period of uncertainty brought about by the COVID-19 pandemic,” says Dr David Sarphie, CEO of Bio Nano Consulting and its parent company, AquAffirm Ltd.
Contact us here if you are interested in learning how we could customise your website with epidemic modelling software.
Take a look:
AquAffirm is a London-based product development company commercialising technologies to address global biomedical and environmental issues. Offering both hardware and digital solutions, the company is focused on tackling some of the world’s most intractable problems. With a world class board comprising a PowderJect co-founder (Dr David Sarphie, CEO), a co-inventor of the blood glucose test (Prof Tony Cass FRSC of Imperial College), a world-renowned microwave engineer and physicist (Prof Gabriel Aeppli FRS of ETH in Switzerland) and an internationally-recognised former director of large UK laboratories (Prof John Wood FREng), AquAffirm is a leader in developing advanced technology solutions.
For more information, please contact Dr David Sarphie on +44 (0)7771 802145 or e-mail: firstname.lastname@example.org